Effects of soy and other natural products on LDL:HDL ratio and other lipid parameters: A literature review

Advances in Therapy

Volumn 20, Issue 1, 2003, Pages 50-78

  Hermansen, Kjeld ^a,d   Dinesen, Bo ^b   Hoie, Lars H ^b   Morgenstern, Eve ^c   Gruenwald, Joerg ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Nutri Pharma ASA   (Denmark)

^c Nutri Pharma GmbH   (Germany)

^d Nutri Pharma ASA   (Norway)

Author keywords

Beta glucan; Cardiovascular disease; Dietary fiber; Hypercholesterolemia; Lipid lowering; Phytosterol; Soy protein

Indexed keywords

ABACOR; ABALON; ANTILIPEMIC AGENT; BETA GLUCAN; CHOLESTEROL; ESTER DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; ISPAGULA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MARGARINE; NATURAL PRODUCT; PHOSPHOLIPID; PHYTOSTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIETARY FIBER; DIETARY INTAKE; DRUG EFFECT; DRUG EFFICACY; GARLIC; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; NONHUMAN; PARAMETER; REVIEW; WHEAT BRAN;

EID: 0038667913     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850119     Document Type: Review

References (71)

1. Isles CG, Paterson JR. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy. Q J Med. 2000;93:567-574.
2. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. 2000;284:311-318.
3. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2000:1-22.
4. Food and Drug Administration. Food labeling: health claims; oats and coronary heart disease; final rule (21 CFR part 101). Federal Register. January 23, 1997:3583-3601.
5. Food and Drug Administration. Food labeling: health claims; soluble fiber from certain foods and coronary heart disease; final rule (21 CFR part 101). Federal Register. February 18, 1998:8103-8121.
6. Food and Drug Administration. Food labeling: health claims; plant sterol/stanol esters and coronary heart disease; interim final rule (21 CFR part 101). Federal Register. September 8, 2000:54686-54739.
7. Food and Drug Administration. Food labeling: health claims; soy protein; interim final rule (21 CFR part 101.82). Federal Register. October 26, 1999:57700-57733.
8. Marsland C. A soy tutorial. Nutritional World. 2000;96-101.
9. Young VR. Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc. 1991;91:828-835.
10. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276-282.
11. Puska P, Korpelainen V, Hoie LH, Skovlund E, Lahti T, Smerud KT. Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial. Eur J Clin Nutr. 2002;56:352-357.
12. Puska P, Korpelainen V, Hoie LH, Skovlund E, Smerud KT. Soy-fibre yogurt improves plasma lipids in hypercholesterolaemia: a double-blind, placebo-controlled trial. In press.
13. Tonstad S, Hoie L, Smerud KT. Effects of 2 doses of soy protein versus casein on serum lipids and lipoproteins and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr. 2002;76:78-84.
14. Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular disease risk markers in type 2 diabetic subjects. Diabetes Care. 2001;24:228-233.
15. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW, Hasler CM. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr. 2000;71:1077-1084.
16. Baum JA, Teng H, Erdman JW, et al. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr. 1998;68:545-551.
17. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med. 1999;159:2070-2076.
18. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 1999;6:7-13.
19. Wong WW, Smith EO, Stuff JE, Hachey DL, Heird WC, Pownell HJ. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr. 1998;68:1385S-1389S.
20. Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000;71:1462-1469.
21. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr. 2001;73:225-231.
22. Ashton E, Ball M. Effects of soy as tofu vs meat on lipoprotein concentrations. Eur J Clin Nutr. 2000;54:14-19.
23. Kurowska EM, Jordan J, Spence JD, et al. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia. Clin Invest Med. 1997;20:162-170.
24. Brown L, Rosner B, Willet WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30-42.
25. Nordgaard I, Hove H, Clausen MR, Mortensen PB. Colonic production of butyrate in patients with previous colonic cancer during long-term treatment with dietary fibre (Plantago ovata seeds). Scand J Gastroenterol. 1996;31:1011-1020.
26. Lia A, Andersson H, Mekki N, Juhel C, Senft M, Lairon D. Postprandial lipemia in relation to sterol and fat excretion in ileostomy subjects given oat-bran and wheat test meals. Am J Clin Nutr. 1997;66:357-365.
27. Hendler SS, Rorvik MS, Fleming T, Deutsch M, Wyble C, eds. Psyllium. In: PDR® for Nutritional Supplements. Montvale, NJ: Thomson Healthcare; 2001:384-386.
28. Anderson JW, Allgood LD, Lawrence A, Altringer LA, Jerdack GR, Hengehold DA. Cholesterollowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr. 2000;71:472-479.
29. Davidson MH, Maki KC, Kong JC, et al. Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia. Am J Clin Nutr. 1998;67:367-376.
30. Anderson JW, Davidson MH, Blonde L, et al. Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr. 2000;71:1433-1438.
31. MacMahon M, Carless J. Ispaghula husk in the treatment of hypercholesterolaemia: a double-blind controlled study. J Cardiovasc Risk. 1998;5:167-172.
32. Rodriguez-Morán M, Guerrero-Romero F, Lazcano-Burciaga G. Lipid- and glucose-lowering efficacy of plantago psyllium in type II diabetes. J Diabetes Complications. 1998;12:273-278.
33. Romero AL, Romero JE, Galaviz S, Fernandez ML. Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from northern Mexico. J Am Coll Nutr. 1998;17:601-608.
34. Gerhardt AL, Gallo NB. Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans. J Nutr. 1998;128:865-869.
35. Behall KM, Scholfield DJ, Hallfrisch J. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women. J Am Coll Nutr. 1997;16:46-51.
36. Önning G, Wallmark A, Persson M, Akesson B, Elmstahl S, Öste R. Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab. 1999;43:301-309.
37. Lovegrove JA, Clohessy A, Milon H, Williams CM. Modest doses of β-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr. 2000;72:49-55.
38. Beer MU, Arrigoni E, Amadò R. Effects of oat gum on blood cholesterol levels in healthy young men. Eur J Clin Nutr. 1995;49:517-522.
39. Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc. 1996;96:1254-1261.
40. Plat J, Mensink RP. Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non-hypercholesterolemic subjects. Atherosclerosis. 2000;148:101-112.
41. Ling WH, Jones PJH. Minireview. Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci. 1995;57:195-206.
42. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995;333:1308-1312.
43. Miettinen TA, Vuoristo M, Nissinen M, Järvinen HJ, Gylling H. Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr. 2000;71:1095-1102.
44. Blair SN, Capuzzi DM, Gottlieb SO, Nguyen T, Morgan JM, Cater NB. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol. 2000;86:46-52.
45. Hallikainen MA, Uusitupa MIJ. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr. 1999;69:403-410.
46. Hallikainen MA, Sarkkinen ES, Uusitupa MIJ. Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr. 2000;130:767-776.
47. Gylling H, Miettinen TA. Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism. 1999;48:575-580.
48. Weststrate JA, Meijer GW. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1998;52:334-343.
49. Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res. 2000;41:697-705.
50. Jones PJH, Ntanios FY, Raeini-Sarjaz M, Vanstone CA. Cholesterol-lowering efficacy of a sitostanolcontaining phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr. 1999;69:1144-1150.
51. Denke MA. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr. 1995;61:392-396.
52. Hendriks HFJ, Weststrate JA, van Vliet T, Meijer GW. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1999;53:319-327.
53. Ayesh R, Weststrate A, Drewitt PN, Hepburn PA. Safety evaluation of phytosterol esters, Part 5: faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food Chem Toxicol. 1999;37:1127-1138.
54. Silagy C, Neil A. Garlic as a lipid lowering agent - a meta-analysis. J R Coll Physicians Lond. 1994;28:2-8.
55. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. Ann Intern Med. 1993;119:599-605.
56. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med. 2000;133:420-429.
57. Neil HAW, Silagy CA, Lancaster T, et al. Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Physicians Lond. 1996;30:329-334.
58. Simons LA, Balasubramaniam S, Königsmark M, Parfitt A, Simons J, Peters W. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis. 1995;113:219-225.
59. Bordia A, Verma SK, Srivastava KC. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins, Leukot Essent Fatty Acids. 1998;58:257-263.
60. Yeh YY, Liu L. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr. 2001;131:989S-993S.
61. Gardner CD, Chatterjee LM, Carlson JJ. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis. 2001;154:213-220.
62. Superko HR, Krauss RM. Garlic powder: effect on plasma lipids, postprandial lipemia, lowdensity lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein (a). J Am Coll Cardiol. 2000;35:321-326.
63. Lash JP, Cardoso LR, Mesler PM, Walczak DA, Pollak R. The effect of garlic on hypercholesterolemia in renal transplant patients. Transplant Proc. 1998;30:189-191.
64. Isaacsohn JL, Moser M, Stein EA, et al. Garlic powder and plasma lipids and lipoproteins. A multicenter, randomized, placebo-controlled trial. Arch Intern Med. 1998;158:1189-1194.
65. Hendler SS, Rorvik MS, Fleming T, Deutsch M, Wyble C, eds. Soy isoflavones, soy proteins. In: PDR® for Nutritional Supplements. Montvale, NJ: Thomson Healthcare; 2001:428-431.
66. Olson BH, Anderson SM, Becker MP, et al. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a metaanalysis. J Nutr. 1997;127:1973-1980.
67. Wood PJ, Beer MU. Functional oat products. In: Mazza G, ed. Functional Foods. Basel: Technomic; 1998:1-37.
68. Lo GS, Goldberg AP, Lim A, Grundhauser JJ, Anderson C, Schonfeld G. Soy fiber improves lipid and carbohydrate metabolism in primary hyperlipidemic subjects. Atherosclerosis. 1986;62:239-248.
69. Anderson JW, Deakins DA, Floore TL, Smith BM, Whitis SE. Dietary fiber and coronary heart disease. Crit Rev Food Sci Nutr. 1990;29:95-147.
70. Miettinen TA. Stanol esters in treatment of hypercholesterolaemia. Eur Heart J Suppl. 1999;1(suppl S):S50-S57.
71. Spigelski D, Jones PJH. Efficacy of garlic supplementation in lowering serum cholesterol levels. Nutr Rev. 2001;59:236-244.